Posted by Michael Wonder on 02 Apr 2025
Sanofi launches new cholesterol lowering injection in Korea with health insurance coverage
1 April 2025 - Sanofi Korea announced the launch of Praluent Pen 300 mg (alirocumab) today following its inclusion in the national health insurance reimbursement list.
The new formulation is designed to provide a more convenient and effective treatment option for patients with high cholesterol and cardiovascular risk.
